Medical Devices Industry Reports Test Phantom | Page 2

REPORT DESCRIPTION
Test Phantom Market – Overview
Increasing prevalence of various chronic diseases such as HIV, tuberculosis, and cancer is expected to contribute
to significant growth of the test phantom market. For instance, according to the World Health Organization key
fact 2018, cancer was the second leading cause of death worldwide and was responsible for 8.8 million deaths in
2015. Moreover, medical imaging is one of the important parts of healthcare industry, as nearly all the diagnostics
and treatment are based upon the analysis provided by the imaging techniques.
Increasing use of imaging techniques in the healthcare sector is expected to propel growth of the test phantom
market. For instance, according to National Health Services (U.K.) diagnostic imaging dataset statistical release,
around 41 million medical imaging tests were reported in England in 2017, 3.49 million imaging tests were
recorded in January 2017, with radiograph being performed 1.89 million times, followed by diagnostic
ultrasonography (Ultrasound, 0.77 million), computerized axial tomography (CT scan, 0.40 million), and
magnetic resonance imaging (MRI, 0.28 million).
Furthermore, government funding for enhanced imaging solutions is expected to significantly boost the market
growth. For instance, in 2014, the U.K Government funded US$ 27,327,000 to build an Imaging Center for
Excellence (ICE) at the University of Glasgow. However, high maintenance cost related with medical test
phantoms is expected to hamper the market growth.